Influence of Opioid Consumption on Serum Prostate-specific Antigen Levels in Men Without Clinical Evidence of Prostate Cancer

Autor: Hosseini, Seyed Yousef, Amini, Erfan, Safarinejad, Mohammad Reza, Soleimani, Mohammad, Lashay, Alireza, Farokhpey, Amir Hossein

Publikováno v: In Urology July 2012 80(1):169-173

Is active surveillance an appropriate approach to manage prostate cancer patients with Gleason Score 3+3 who met the criteria for active surveillance?

Autor: Ghiasy, Saleh, Abedi, Amir Reza, Moradi, Afshin, Hosseini, Seyed Yousef, Karkan, Morteza Fallah, Sadri, Ghazal, Davari, Mohammadreza

Publikováno v: Turkish Journal of Urology; Jul2019, Vol. 45 Issue 4, p261-264, 4p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Is active surveillance an appropriate approach to manage prostate cancer patients with Gleason Score 3+3 who met the criteria for active surveillance?

Autor: Ghiasy S; Infertility and Reproductive Health Research Center (irhrc), Shahid Beheshti Medical Science University, Tehran, Iran., Abedi AR; Department of Urology, Shohadae-tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Moradi A; Department of Pathology, Shohadae-tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Hosseini SY; Department of Urology, Shahid Modares Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Karkan MF; Infertility and Reproductive Health Research Center (irhrc), Shahid Beheshti Medical Science University, Tehran, Iran., Sadri G; Department of Radiology. Iran University of Medical Sciences, Tehran, Iran., Davari M; Infertility and Reproductive Health Research Center (irhrc), Shahid Beheshti Medical Science University, Tehran, Iran.

Publikováno v: Turkish journal of urology [Turk J Urol] 2018 Nov 19; Vol. 45 (4), pp. 261-264. Date of Electronic Publication: 2018 Nov 19 (Print Publication: 2019).

Prognostic Value of Promoter Hypermethylation of Retinoic Acid Receptor Beta (RARB) and CDKN2 (p16/MTS1) in Prostate Cancer.

Autor: Ameri A; Department of Radiation Oncology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran;, Alidoosti A, Hosseini SY, Parvin M, Emranpour MH, Taslimi F, Salehi E, Fadavip P

Publikováno v: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu [Chin J Cancer Res] 2011 Dec; Vol. 23 (4), pp. 306-11.